Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
OMI Stock Forecast 2026-2027
$3.63
Current Price
$264.53M
Market Cap
Buy 1
Hold 2
Sell 2
Wall St Analyst Ratings
Distance to OMI Price Targets
+92.8%
To High Target of $7.00
+51.5%
To Median Target of $5.50
+10.2%
To Low Target of $4.00
OMI Price Momentum
+10.0%
1 Week Change
+18.2%
1 Month Change
-54.2%
1 Year Change
+29.6%
Year-to-Date Change
-56.8%
From 52W High of $8.40
+97.3%
From 52W Low of $1.84
📊 TOP ANALYST CALLS
Did OMI Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Owens & Minor is one of their latest high-conviction picks.
Latest OMI Stock Price Targets & Analyst Predictions
Based on our analysis of 16 Wall Street analysts, OMI has a neutral consensus with a median price target of $5.50 (ranging from $4.00 to $7.00). The overall analyst rating is Buy (6.0/10). Currently trading at $3.63, the median forecast implies a 51.5% upside. This outlook is supported by 1 Buy, 2 Hold, and 2 Sell ratings.
The most optimistic forecast comes from Kevin Caliendo at UBS, projecting a 92.8% upside. Conversely, the most conservative target is provided by Kevin Caliendo at UBS, suggesting a 10.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
OMI Analyst Ratings
1
Buy
2
Hold
2
Sell
OMI Price Target Range
Low
$4.00
Average
$5.50
High
$7.00
Current: $3.63
Latest OMI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for OMI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 9, 2026 | Citigroup | Buy | Maintains | $N/A | |
| Nov 3, 2025 | UBS | Kevin Caliendo | Neutral | Downgrade | $4.00 |
| Aug 27, 2025 | JP Morgan | Lisa Gill | Underweight | Maintains | $6.00 |
| Aug 13, 2025 | UBS | Kevin Caliendo | Buy | Maintains | $7.00 |
| Aug 12, 2025 | Baird | Eric Coldwell | Outperform | Maintains | $7.00 |
| Aug 12, 2025 | Citigroup | Daniel Grosslight | Buy | Maintains | $7.00 |
| Aug 12, 2025 | B of A Securities | Allen Lutz | Underperform | Maintains | $4.75 |
| Jun 6, 2025 | Baird | Eric Coldwell | Neutral | Maintains | $10.00 |
| Apr 17, 2025 | Citigroup | Daniel Grosslight | Buy | Maintains | $11.00 |
| Mar 10, 2025 | JP Morgan | Michael Minchak | Underweight | Maintains | $10.00 |
| Mar 3, 2025 | Baird | Eric Coldwell | Neutral | Maintains | $11.00 |
| Feb 25, 2025 | Baird | Eric Coldwell | Neutral | Maintains | $10.00 |
| Feb 13, 2025 | UBS | Kevin Caliendo | Buy | Maintains | $13.00 |
| Feb 4, 2025 | Baird | Eric Coldwell | Neutral | Maintains | $14.00 |
| Nov 5, 2024 | UBS | Kevin Caliendo | Buy | Maintains | $25.00 |
| Nov 5, 2024 | Citigroup | Daniel Grosslight | Buy | Maintains | $18.50 |
| Nov 5, 2024 | Barclays | Steven Valiquette | Equal-Weight | Maintains | $14.00 |
| Nov 5, 2024 | Baird | Eric Coldwell | Neutral | Maintains | $14.00 |
| Aug 21, 2024 | JP Morgan | Lisa Gill | Underweight | Maintains | $18.00 |
| Aug 5, 2024 | Barclays | Steven Valiquette | Equal-Weight | Maintains | $18.00 |
Owens & Minor Inc. (OMI) Competitors
The following stocks are similar to Owens & Minor based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
OMI
Owens & Minor
mkt cap
245.19M
Owens & Minor Inc. (OMI) Financial Data
Valuation Metrics
Market Cap
$264.53M
Enterprise Value
$2.43B
P/E Ratio
N/A
PEG Ratio
2.9x
Price/Sales
0.0x
Growth & Margins
Revenue Growth (YoY)
+1.5%
Gross Margin
+45.6%
Operating Margin
+8.1%
Net Margin
-12.4%
EPS Growth
-73.7%
Financial Health
Cash/Price Ratio
+11.7%
Current Ratio
0.9x
Debt/Equity
-4.9x
ROE
-196.4%
ROA
+3.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Owens & Minor Inc. (OMI) Business Model
About Owens & Minor Inc.
What They Do
Healthcare solutions company for medical supply distribution.
Business Model
Owens & Minor Inc. generates revenue primarily through the distribution of medical and surgical supplies to healthcare providers globally. The company also profits from its proprietary products segment, which includes surgical kits and custom procedure trays, catering to the needs of surgical settings and enhancing healthcare delivery.
Additional Information
Headquartered in Mechanicsville, Virginia, Owens & Minor is crucial in maintaining the supply chain efficiency for hospitals, health networks, and extended care markets. The company is committed to improving healthcare operations while ensuring the availability of essential products.
Company Information
Sector
Healthcare
Industry
Medical Distribution
Employees
23,200
CEO
Mr. Edward A. Pesicka
Country
United States
IPO Year
1988
Website
www.owens-minor.comOwens & Minor Inc. (OMI) Latest News & Analysis
Latest News
Owens & Minor, Inc. Completes Sale of Products & Healthcare Services Business to Platinum Equity
6 months ago
Quick Summary
Owens & Minor, Inc. has sold its Products & Healthcare Services segment and rebranded as Accendra Health, focusing on home-based care. The transaction was completed with Platinum Equity.
Why It Matters
The sale of Owens & Minor's P&HS segment marks a strategic shift to focus on home-based care, potentially enhancing growth prospects and investor appeal in the evolving healthcare market.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Owens & Minor, Inc. (NYSE: OMI) will change its name to Accendra Health, Inc. effective December 31, 2025, to align with its focus on home-based care. Operations under Apria and Byram Healthcare will continue.
Why It Matters
Owens & Minor's name change to Accendra Health reflects a strategic shift towards home-based care, signaling potential growth opportunities and a focus on evolving healthcare trends.
Source: Business Wire
Market Sentiment:
Neutral
Owens & Minor, Inc. (OMI) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
7 months ago
Quick Summary
Owens & Minor, Inc. (OMI) presented at the Citi Annual Global Healthcare Conference 2025, highlighting its strategies and insights relevant to investors.
Why It Matters
Owens & Minor's presentation at a major healthcare conference may indicate strategic plans, potential growth opportunities, and investor sentiment, impacting stock performance and market perceptions.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Owens & Minor, Inc. (NYSE: OMI) will participate in the Citi 2025 Global Healthcare Conference on December 2, 2025, with a fireside chat featuring CEO Ed Pesicka and VP Will Parrish at 2:30 PM ET.
Why It Matters
Management participation in investor conferences signals transparency and potential strategic insights, which can influence investor confidence and stock performance for Owens & Minor, Inc.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Owens & Minor, Inc. will hold its Q3 2025 earnings call on October 30, 2025, at 5:00 PM EDT, featuring key executives including CEO Edward Pesicka and CFO Jonathan Leon.
Why It Matters
Owens & Minor's Q3 2025 earnings call provides insights into the company's financial health and future outlook, influencing investor sentiment and stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Owens & Minor, Inc. (NYSE: OMI) reported Q3 2025 financial results, focusing on continuing operations and announcing the sale of its Products & Healthcare Services segment as part of its strategic pivot.
Why It Matters
Owens & Minor's Q3 results reveal a strategic shift after selling its Products & Healthcare Services segment, indicating a focus on core operations that could affect future growth and profitability.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About OMI Stock
What is Owens & Minor Inc.'s (OMI) stock forecast for 2027?
Based on our analysis of 16 Wall Street analysts, Owens & Minor Inc. (OMI) has a median price target of $5.50. The highest price target is $7.00 and the lowest is $4.00.
Is OMI stock a good investment in 2027?
According to current analyst ratings, OMI has 1 Buy ratings, 2 Hold ratings, and 2 Sell ratings. The stock is currently trading at $3.63. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for OMI stock?
Wall Street analysts predict OMI stock could reach $5.50 in the next 12 months. This represents a 51.5% increase from the current price of $3.63. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Owens & Minor Inc.'s business model?
Owens & Minor Inc. generates revenue primarily through the distribution of medical and surgical supplies to healthcare providers globally. The company also profits from its proprietary products segment, which includes surgical kits and custom procedure trays, catering to the needs of surgical settings and enhancing healthcare delivery.
What is the highest forecasted price for OMI Owens & Minor Inc.?
The highest price target for OMI is $7.00 from Kevin Caliendo at UBS, which represents a 92.8% increase from the current price of $3.63.
What is the lowest forecasted price for OMI Owens & Minor Inc.?
The lowest price target for OMI is $4.00 from Kevin Caliendo at UBS, which represents a 10.2% increase from the current price of $3.63.
What is the overall OMI consensus from analysts for Owens & Minor Inc.?
The overall analyst consensus for OMI is neutral. Out of 16 Wall Street analysts, 1 rate it as Buy, 2 as Hold, and 2 as Sell, with a median price target of $5.50.
How accurate are OMI stock price projections?
Stock price projections, including those for Owens & Minor Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 16, 2026 2:51 AM UTC